Pfizer's suffering from generics, but 'innovation for growth'—not big M&A—is still the mantra - FiercePharma

  1. Pfizer's suffering from generics, but 'innovation for growth'—not big M&A—is still the mantra  FiercePharma
  2. Pfizer's earnings outlook disappoints after Viagra loses patent protection and Lyrica faces same fate  CNBC
  3. Pfizer quarterly profit in line, touts pipeline of future products  Yahoo Finance
  4. Pfizer Tops Q4 Earnings But Guides for Weaker 2019 as Lyrica Exclusivity Ends  TheStreet.com
  5. Pfizer's Outlook Disappoints as Drugmaker Focuses on Pipeline  Bloomberg
  6. View full coverage on Google News


from Top stories - Google News January 29, 2019 at 11:48PM

Comments

Popular posts from this blog

Jared Leto Was Responsible for the "We Live in a Society" Line in the 'Zack Snyder's Justice League' Trailer - /FILM

How to keep Amazon, Apple, and Google from listening to your Alexa, Siri, and Assistant recordings - TechHive

Exclusive: IAEA found uranium traces at Iran 'atomic warehouse' - diplomats - Reuters